MedTrace Logo

Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD

NCT02330952 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2025-09-11

No results posted yet for this study

Summary

Primary objective:

The aim of this study is to determine the efficacy and safety of five days of oral corticosteroids (40 mg / day) for the treatment of acute exacerbations of COPD (AECOPD) in outpatients.

Conditions

  • Pulmonary Disease
  • Chronic Obstructive (MeSH)

Interventions

DRUG

Prednisone

40mg/day per os for 5 days

DRUG

Placebo

40mg/day per os for 5 days

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Christian Ghasarossian, MD · Département de Médecine Générale Faculté de Médecine Paris Descartes

  • Nicolas Roche, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Thomas Similowski, MD, PhD · Université Paris 6, Inserm, APHP

  • Jean-Laurent Thebault, MD · Département de Médecine Générale Faculté de Médecine Paris Descartes

  • Alain Lorenzo, MD · Département de Médecine Générale Faculté de Médecine Paris Descartes

  • François Bloede, MD · Département de Médecine Générale Faculté de Médecine Paris Descartes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-10
Primary Completion
2017-05-23
Completion
2017-05-23

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02330952 on ClinicalTrials.gov